Works about MULTIPLE myeloma treatment

Results: 1776

Potential of Revlimid.
Published in:
Practice Nursing, 2010, v. 21, n. 1, p. 47
Publication type:
Article
Stem Cell Transplants for Multiple Myeloma: Is it Right for Me?
Published in:
Blood & Marrow Transplant Newsletter, 2009, v. 19, n. 1, p. 1
Publication type:
Article
Occlusal Palliation of a Hematopoietic Stem Cell Transplant Patient.
Published in:
2018
By:
- Pada, Hilary
Publication type:
journal article
Methodological aspects of health‐related quality of life measurement and analysis in patients with multiple myeloma.
Published in:
Angewandte Chemie, 2019, v. 131, n. 15, p. 11, doi. 10.1111/bjh.15759
By:
- Nielsen, Lene Kongsgaard;
- Abildgaard, Niels;
- Jarden, Mary;
- Klausen, Tobias Wirenfeld
Publication type:
Article
Infectious and immunological sequelae of daratumumab in multiple myeloma.
Published in:
Angewandte Chemie, 2019, v. 131, n. 15, p. 187, doi. 10.1111/bjh.15433
By:
- Johnsrud, Andrew J.;
- Johnsrud, Joyce J.;
- Susanibar, Sandra A.;
- Kamimoto, Jorge J.;
- Kothari, Atul;
- Burgess, Mary;
- Van Rhee, Frits;
- Rico, Juan C.
Publication type:
Article
HAX‐1 overexpression in multiple myeloma is associated with poor survival.
Published in:
Angewandte Chemie, 2019, v. 131, n. 15, p. 179, doi. 10.1111/bjh.15430
By:
- Feng, Xiaoli;
- Kwiecinska, Anna;
- Rossmann, Eva;
- Bottai, Matteo;
- Ishikawa, Taichi;
- Patarroyo, Manuel;
- Österborg, Anders;
- Porwit, Anna;
- Zheng, Chengyun;
- Fadeel, Bengt
Publication type:
Article
Diagnosis and treatment of multiple myeloma and AL amyloidosis with focus on improvement of renal lesion.
Published in:
Clinical & Experimental Nephrology, 2012, v. 16, n. 5, p. 659, doi. 10.1007/s10157-012-0684-5
By:
- Suzuki, Kenshi
Publication type:
Article
Galectin-8 enhances adhesion of multiple myeloma cells to vascular endothelium and is an adverse prognostic factor.
Published in:
Glycobiology, 2016, v. 26, n. 10, p. 1048, doi. 10.1093/glycob/cww066
By:
- Friedel, Myriam;
- André, Sabine;
- Goldschmidt, Hartmut;
- Gabius, Hans-Joachim;
- Schwartz-Albiez, Reinhard
Publication type:
Article
The Real World Effectiveness of Hematopoietic Transplant Among Elderly Individuals With Multiple Myeloma.
Published in:
JNCI: Journal of the National Cancer Institute, 2015, v. 107, n. 8, p. 1, doi. 10.1093/jnci/djv139
By:
- Winn, Aaron N.;
- Shah, Gunjan L.;
- Cohen, Joshua T.;
- Pei-Jung Lin;
- Parsons, Susan K.
Publication type:
Article
The Real World Effectiveness of Hematopoietic Transplant Among Elderly Individuals With Multiple Myeloma.
Published in:
JNCI: Journal of the National Cancer Institute, 2015, v. 107, n. 8, p. 1, doi. 10.1093/jnci/djv139
By:
- Winn, Aaron N.;
- Shah, Gunjan L.;
- Cohen, Joshua T.;
- Pei-Jung Lin;
- Parsons, Susan K.
Publication type:
Article
FDA Approves New Agent for Multiple Myeloma.
Published in:
JNCI: Journal of the National Cancer Institute, 2015, v. 107, n. 6, p. 5, doi. 10.1093/jnci/djv165
By:
- Fenichel, Marilyn P.
Publication type:
Article
Treating Multiple Myeloma: The Cause for Optimism.
Published in:
JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 5, p. 6, doi. 10.1093/jnci/dju140
By:
- Fenichel, Marilyn P.
Publication type:
Article
Thirteenth Biannual Report of the Cochrane Haematological Malignancies Group—Focus on Multiple Myeloma.
Published in:
JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 17, p. E1, doi. 10.1093/jnci/djr271
By:
- Bauer, Kathrin;
- Rancea, Michaela;
- Schmidtke, Bettina;
- Kluge, Sabine;
- Monsef, Ina;
- Hübel, Kai;
- Engert, Andreas;
- Skoetz, Nicole
Publication type:
Article
Researchers Debate Best Use of Stem Cell Transplants in Patients With Multiple Myeloma.
Published in:
JNCI: Journal of the National Cancer Institute, 2009, v. 101, n. 23, p. 1608, doi. 10.1093/jnci/djp434
By:
- Rowan, Karen
Publication type:
Article
Re: Tandem vs Single Autologous Hematopoietic Cell Transplantation for the Treatment of Multiple Myeloma: A Systematic Review and Meta-analysis.
Published in:
JNCI: Journal of the National Cancer Institute, 2009, v. 101, n. 20, p. 1430, doi. 10.1093/jnci/djp320
By:
- MEHTA, JAYESH
Publication type:
Article
Gene Mutation Revelation Points to New Target for Myeloma Treatment, Studies Say.
Published in:
JNCI: Journal of the National Cancer Institute, 2007, v. 99, n. 18, p. 1362, doi. 10.1093/jnci/djm164
By:
- Garber, Ken
Publication type:
Article
Bortezomib May Be More Effective, but More Toxic, for Multiple Myeloma.
Published in:
JNCI: Journal of the National Cancer Institute, 2005, v. 97, n. 14, p. 1031
By:
- Hayasaka, Elana;
- Zielinski, Sarah I.
Publication type:
Article
Missing the target: ubiquitin ligase drugs stall.
Published in:
2005
By:
- Garber, Ken
Publication type:
journal article
Naphthoquinone amino acid derivatives, synthesis and biological activity as proteasome inhibitors.
Published in:
Journal of Enzyme Inhibition & Medicinal Chemistry, 2017, v. 32, n. 1, p. 865, doi. 10.1080/14756366.2017.1334649
By:
- Marastoni, Mauro;
- Trapella, Claudio;
- Scotti, Alessandra;
- Fantinati, Anna;
- Ferretti, Valeria;
- Marzola, Erika;
- Eleonora, Gallerani;
- Gavioli, Riccardo;
- Preti, Delia
Publication type:
Article
Clinical Impact of Bortezomib in Frontline Regimens for Patients with Multiple Myeloma.
Published in:
Oncologist, 2007, v. 12, n. 8, p. 978, doi. 10.1634/theoncologist.12-8-978
By:
- Manochakian, Rami;
- Miller, Kena C.;
- Chanan-Khan, Asher A.
Publication type:
Article
What do we learned from new treatment of multiple myeloma?
Published in:
Macedonian Pharmaceutical Bulletin / Makedonsko Farmacevtski Bilten, 2016, v. 62, p. 529
By:
- Stavrik, Sonja Genadieva
Publication type:
Article
First-in-Human CAR T-Cell Trial Shows Activity in Multiple Myeloma.
Published in:
Personalized Medicine in Oncology, 2016, v. 5, n. 2, p. 93
By:
- Kochenderfer, James
Publication type:
Article
Multiple Myeloma and the MMRF CoMMpass Study: Revolutionizing Clinical Trial Data Dissemination.
Published in:
2013
By:
- Capone, Walter M.;
- Jagannath, Sundar;
- Lonial, Sagar;
- Orloff, Gregory
Publication type:
Interview
Lenalidomide and dexamethasone with or without clarithromycin in patients with multiple myeloma ineligible for autologous transplant: a randomized trial.
Published in:
Blood Cancer Journal, 2021, v. 11, n. 5, p. 1, doi. 10.1038/s41408-021-00490-8
By:
- Puig, Noemi;
- Hernández, Miguel T.;
- Rosiñol, Laura;
- González, Esther;
- de Arriba, Felipe;
- Oriol, Albert;
- González-Calle, Verónica;
- Escalante, Fernando;
- de la Rubia, Javier;
- Gironella, Mercedes;
- Ríos, Rafael;
- García-Sánchez, Ricarda;
- Arguiñano, José M.;
- Alegre, Adrián;
- Martín, Jesús;
- Gutiérrez, Norma. C.;
- Calasanz, María J.;
- Martín, María L.;
- Couto, María del Carmen;
- Casanova, María
Publication type:
Article
Characteristics and outcomes of therapy-related myeloid neoplasms following autologous stem cell transplantation for multiple myeloma.
Published in:
2021
By:
- Nadiminti, Kalyan;
- Sidiqi, M. Hasib;
- Meleveedu, Kapil;
- Alkhateeb, Hassan B.;
- Hogan, William J.;
- Litzow, Mark;
- Patnaik, Mrinal;
- Kumar, Shaji;
- Gertz, Morie;
- Chen, Dong;
- Shah, Mithun Vinod
Publication type:
Letter
Therapeutic outcome of early-phase clinical trials in multiple myeloma: a meta-analysis.
Published in:
Blood Cancer Journal, 2021, v. 11, n. 3, p. 1, doi. 10.1038/s41408-021-00441-3
By:
- van Nieuwenhuijzen, Niels;
- Frunt, Rowan;
- May, Anne M.;
- Minnema, Monique C.
Publication type:
Article
Relapsed multiple myeloma demonstrates distinct patterns of immune microenvironment and malignant cell-mediated immunosuppression.
Published in:
Blood Cancer Journal, 2021, v. 11, n. 3, p. 1, doi. 10.1038/s41408-021-00440-4
By:
- Visram, Alissa;
- Dasari, Surendra;
- Anderson, Emilie;
- Kumar, Shaji;
- Kourelis, Taxiarchis V.
Publication type:
Article
Predictive biomarkers with isatuximab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma.
Published in:
2021
By:
- Richardson, Paul G.;
- Facon, Thierry;
- Bensinger, William I.;
- Leleu, Xavier;
- Campana, Frank;
- Macé, Sandrine;
- Chiron, Marielle;
- van de Velde, Helgi;
- Mikhael, Joseph
Publication type:
Letter
Preclinical development of CD126 CAR-T cells with broad antitumor activity.
Published in:
Blood Cancer Journal, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41408-020-00405-z
By:
- Mishra, Ameet K.;
- Kemler, Iris;
- Dingli, David
Publication type:
Article
Effect of autologous hematopoietic stem cell transplant on the development of second primary malignancies in multiple myeloma patients.
Published in:
Blood Cancer Journal, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41408-020-00400-4
By:
- Rosenberg, A. S.;
- Brunson, A.;
- Tuscano, J.;
- Jonas, B. A.;
- Hoeg, R.;
- Wun, T.;
- Keegan, T. H. M.
Publication type:
Article
Venetoclax induces deep hematologic remissions in t(11;14) relapsed/refractory AL amyloidosis.
Published in:
Blood Cancer Journal, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41408-020-00397-w
By:
- Premkumar, Vikram J.;
- Lentzsch, Suzanne;
- Pan, Samuel;
- Bhutani, Divaya;
- Richter, Joshua;
- Jagannath, Sundar;
- Liedtke, Michaela;
- Jaccard, Arnaud;
- Wechalekar, Ashutosh D.;
- Comenzo, Raymond;
- Sanchorawala, Vaishali;
- Royer, Bruno;
- Rosenzweig, Michael;
- Valent, Jason;
- Schönland, Stefan;
- Fonseca, Rafael;
- Wong, Sandy;
- Kapoor, Prashant
Publication type:
Article
Lenalidomide versus bortezomib maintenance after frontline autologous stem cell transplantation for multiple myeloma.
Published in:
Blood Cancer Journal, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41408-020-00390-3
By:
- Baertsch, Marc-Andrea;
- Mai, Elias K.;
- Hielscher, Thomas;
- Bertsch, Uta;
- Salwender, Hans J.;
- Munder, Markus;
- Fuhrmann, Stephan;
- Dührsen, Ulrich;
- Brossart, Peter;
- Neben, Kai;
- Schlenzka, Jana;
- Kunz, Christina;
- Raab, Marc S.;
- Hillengaß, Jens;
- Jauch, Anna;
- Seckinger, Anja;
- Hose, Dirk;
- Luntz, Steffen;
- Sonneveld, Pieter;
- Lokhorst, Henk
Publication type:
Article
Molecular profiling of immunoglobulin heavy-chain gene rearrangements unveils new potential prognostic markers for multiple myeloma patients.
Published in:
Blood Cancer Journal, 2020, v. 10, n. 2, p. 1, doi. 10.1038/s41408-020-0283-8
By:
- Medina, Alejandro;
- Jiménez, Cristina;
- Sarasquete, M. Eugenia;
- González, Marcos;
- Chillón, M. Carmen;
- Balanzategui, Ana;
- Prieto-Conde, Isabel;
- García-Álvarez, María;
- Puig, Noemí;
- González-Calle, Verónica;
- Alcoceba, Miguel;
- Cuenca, Isabel;
- Barrio, Santiago;
- Escalante, Fernando;
- Gutiérrez, Norma C.;
- Gironella, Mercedes;
- Hernández, Miguel T.;
- Sureda, Anna;
- Oriol, Albert;
- Bladé, Joan
Publication type:
Article
Developments in continuous therapy and maintenance treatment approaches for patients with newly diagnosed multiple myeloma.
Published in:
Blood Cancer Journal, 2020, v. 10, n. 2, p. 1, doi. 10.1038/s41408-020-0273-x
By:
- Dimopoulos, Meletios A.;
- Jakubowiak, Andrzej J.;
- McCarthy, Philip L.;
- Orlowski, Robert Z.;
- Attal, Michel;
- Bladé, Joan;
- Goldschmidt, Hartmut;
- Weisel, Katja C.;
- Ramasamy, Karthik;
- Zweegman, Sonja;
- Spencer, Andrew;
- Huang, Jeffrey S. Y.;
- Lu, Jin;
- Sunami, Kazutaka;
- Iida, Shinsuke;
- Chng, Wee-Joo;
- Holstein, Sarah A.;
- Rocci, Alberto;
- Skacel, Tomas;
- Labotka, Richard
Publication type:
Article
Gain of Chromosome 1q is associated with early progression in multiple myeloma patients treated with lenalidomide, bortezomib, and dexamethasone.
Published in:
Blood Cancer Journal, 2019, v. 9, n. 12, p. 1, doi. 10.1038/s41408-019-0254-0
By:
- Schmidt, Timothy M.;
- Barwick, Benjamin G.;
- Joseph, Nisha;
- Heffner, Leonard T.;
- Hofmeister, Craig C.;
- Bernal, Leon;
- Dhodapkar, Madhav V.;
- Gupta, Vikas A.;
- Jaye, David L.;
- Wu, Jiayi;
- Goyal, Subir;
- Chen, Zhengjia;
- Boise, Lawrence H.;
- Lonial, Sagar;
- Nooka, Ajay K.;
- Kaufman, Jonathan L.
Publication type:
Article
Pomalidomide and dexamethasone combination with additional cyclophosphamide in relapsed/refractory multiple myeloma (AMN001)—a trial by the Asian Myeloma Network.
Published in:
Blood Cancer Journal, 2019, v. 9, n. 10, p. N.PAG, doi. 10.1038/s41408-019-0245-1
By:
- Soekojo, Cinnie Yentia;
- Kim, Kihyun;
- Huang, Shang-Yi;
- Chim, Chor-Sang;
- Takezako, Naoki;
- Asaoku, Hideki;
- Kimura, Hideo;
- Kosugi, Hiroshi;
- Sakamoto, Junichi;
- Gopalakrishnan, Sathish Kumar;
- Nagarajan, Chandramouli;
- Wei, Yuan;
- Moorakonda, Rajesh;
- Lee, Shu Ling;
- Lee, Je Jung;
- Yoon, Sung-Soo;
- Kim, Jin Seok;
- Min, Chang Ki;
- Lee, Jae-Hoon;
- Durie, Brian
Publication type:
Article
In response to: Treatment of patients with multiple myeloma progressing on frontline therapy with lenalidomide, Moreau et al., 2019.
Published in:
2019
By:
- Klippel, Zandra;
- Kimball, Amy;
- Tekle, Christina
Publication type:
Letter to the Editor
A phase 1 study of filanesib, carfilzomib, and dexamethasone in patients with relapsed and/or refractory multiple myeloma.
Published in:
2019
By:
- Lee, Hans C.;
- Shah, Jatin J.;
- Feng, Lei;
- Manasanch, Elisabet E.;
- Lu, Rebecca;
- Morphey, Ashley;
- Crumpton, Brandon;
- Patel, Krina K.;
- Wang, Michael L.;
- Alexanian, Raymond;
- Thomas, Sheeba K.;
- Weber, Donna M.;
- Orlowski, Robert Z.
Publication type:
Letter
Cystic transformation of focal lesions after therapy is associated with remission but adverse outcome in myeloma.
Published in:
2019
By:
- Merz, Maximilian;
- Hielscher, Thomas;
- Mai, Elias Karl;
- Seckinger, Anja;
- Hose, Dirk;
- Jauch, Anna;
- Sauer, Sandra;
- Luntz, Steffen;
- Bertsch, Uta;
- Raab, Marc S.;
- Neben, Kai;
- Salwender, Hans;
- Blau, Igor W.;
- Lindemann, Hans-Walter;
- Dürig, Jan;
- Scheid, Christof;
- Haenel, Mathias;
- Weisel, Katja;
- Weber, Tim;
- Delorme, Stefan
Publication type:
Letter
Nelfinavir and lenalidomide/dexamethasone in patients with lenalidomide-refractory multiple myeloma. A phase I/II Trial (SAKK 39/10).
Published in:
Blood Cancer Journal, 2019, v. 9, n. 9, p. N.PAG, doi. 10.1038/s41408-019-0228-2
By:
- Hitz, F.;
- Kraus, M.;
- Pabst, T.;
- Hess, D.;
- Besse, L.;
- Silzle, T.;
- Novak, U.;
- Seipel, K.;
- Rondeau, S.;
- Stüdeli, S.;
- Vilei, S. Berardi;
- Samaras, P.;
- Mey, U.;
- Driessen, C.
Publication type:
Article
Inhibition of E-Selectin (GMI-1271) or E-selectin together with CXCR4 (GMI-1359) re-sensitizes multiple myeloma to therapy.
Published in:
2019
By:
- Muz, Barbara;
- Azab, Feda;
- Fiala, Mark;
- King, Justin;
- Kohnen, Daniel;
- Fogler, William E.;
- Smith, Ted;
- Magnani, John L.;
- Vij, Ravi;
- Azab, Abdel Kareem
Publication type:
Letter
Phase I/II trial of bendamustine, ixazomib, and dexamethasone in relapsed/refractory multiple myeloma.
Published in:
Blood Cancer Journal, 2019, v. 9, n. 8, p. N.PAG, doi. 10.1038/s41408-019-0219-3
By:
- Dhakal, Binod;
- D'Souza, Anita;
- Hamadani, Mehdi;
- Arce-Lara, Carlos;
- Schroeder, Katrina;
- Chhabra, Saurabh;
- Shah, Nirav N.;
- Gauger, Katelyn;
- Keaton, Taylor;
- Pasquini, Marcelo;
- Hari, Parameswaran
Publication type:
Article
Anti-myeloma Effects of Icariin Are Mediated Through the Attenuation of JAK/STAT3-Dependent Signaling Cascade.
Published in:
Frontiers in Pharmacology, 2018, p. 1, doi. 10.3389/fphar.2018.00531
By:
- Young Yun Jung;
- Jong Hyun Lee;
- Dongwoo Nam;
- Narula, Acharan S.;
- Namjoshi, Ojas A.;
- Blough, Bruce E.;
- Jae-Young Um;
- Sethi, Gautam;
- Kwang Seok Ahn
Publication type:
Article
Long-Term Efficacy of Maintenance Therapy for Multiple Myeloma: A Quantitative Synthesis of 22 Randomized Controlled Trials.
Published in:
Frontiers in Pharmacology, 2018, p. 1, doi. 10.3389/fphar.2018.00430
By:
- Li, Jie-Li;
- Fan, Guang-Yu;
- Liu, Yu-Jie;
- Zeng, Zi-Hang;
- Huang, Jing-Juan;
- Yang, Zong-Ming;
- Meng, Xiang-Yu
Publication type:
Article
Sanguinarine Induces Apoptosis Pathway in Multiple Myeloma Cell Lines via Inhibition of the JaK2/STAT3 Signaling.
Published in:
Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00285
By:
- Akhtar, Sabah;
- Achkar, Iman W.;
- Siveen, Kodappully S.;
- Kuttikrishnan, Shilpa;
- Prabhu, Kirti S.;
- Khan, Abdul Q.;
- Ahmed, Eiman I.;
- Sahir, Fairooz;
- Jerobin, Jayakumar;
- Raza, Afsheen;
- Merhi, Maysaloun;
- Elsabah, Hesham M.;
- Taha, Ruba;
- Omri, Halima El;
- Zayed, Hatem;
- Dermime, Said;
- Steinhoff, Martin;
- Uddin, Shahab
Publication type:
Article
MPT0G413, A Novel HDAC6-Selective Inhibitor, and Bortezomib Synergistically Exert Anti-tumor Activity in Multiple Myeloma Cells.
Published in:
Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00249
By:
- Huang, Fang-I;
- Wu, Yi-Wen;
- Sung, Ting-Yi;
- Liou, Jing-Ping;
- Lin, Mei-Hsiang;
- Pan, Shiow-Lin;
- Yang, Chia-Ron
Publication type:
Article
Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma Receiving Immunomodulatory Therapy.
Published in:
Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00045
By:
- Cornell, Robert Frank;
- Goldhaber, Samuel Z.;
- Engelhardt, Brian G.;
- Moslehi, Javid;
- Jagasia, Madan;
- Patton, Daryl;
- Harrell, Shelton;
- Hall, Robert;
- Wyatt, Houston;
- Piazza, Greg
Publication type:
Article
Optimizing dendritic cell vaccine for immunotherapy in multiple myeloma: tumour lysates are more potent tumour antigens than idiotype protein to promote anti-tumour immunity.
Published in:
Clinical & Experimental Immunology, 2012, v. 170, n. 2, p. 167, doi. 10.1111/j.1365-2249.2012.04642.x
By:
- Hong, S.;
- Li, H.;
- Qian, J.;
- Yang, J.;
- Lu, Y.;
- Yi, Q.
Publication type:
Article
Upper Gastrointestinal Bleeding from Gastric Amyloidosis in a Patient with Smoldering Multiple Myeloma.
Published in:
Case Reports in Gastrointestinal Medicine, 2015, v. 2015, p. 1, doi. 10.1155/2015/320120
By:
- Gjeorgjievski, Mihajlo;
- Purohit, Treta;
- Amin, Mitual B.;
- Kurtin, Paul J.;
- Cappell, Mitchell S.
Publication type:
Article
FORGIVE SINS: RISE OF THALIDOMIDE.
Published in:
Our Dermatology Online / Nasza Dermatologia Online, 2014, v. 5, n. 2, p. 190, doi. 10.7241/ourd.20142.48
By:
- Inakanti, Yugandar;
- Kumar, Shiva
Publication type:
Article